Alzheimer; News from the web:
Today’s link is a more in depth explanation of the discovery of the working of nuclear receptors. Certain nuclear receptors are essential for long-term memory formation, and pharmaceutical approaches that boost the function of these proteins — and the molecular machinery they set in motion — could one day restore memory function in those who have lost it.
Read all about it HERE
visit us at AlzheimerHeadlines.com
Alzheimer; News from the web:
Well the article in the Huffington post this morning certainly burst the bubble of many people who had relied on this herb.
A trail in France, an article in the Lancet for Neurology and an opinion from the Alzheimer association killed the hype and the consensus is that anyone who buys this over the counter herb in the expectation that it will do anything to slow down or prevent the disease, is wasting their money.
Read all about it HERE
visit us at AlzheimerHeadlines.com
Alzheimer; News from the web:
Over at nature they have provided a great overview over the current state of affairs concerning Alzheimer drugs and research.
They also highlight the enormous costs involved in doing the clinical trails and some of the devastating results we saw this summer.
It is difficult to keep investors interested and motivated but lately there are some new paths that may just be worth exploring. Great article
Read all about it HERE
visit us at AlzheimerHeadlines.com
Alzheimer; News from the web:
Researchers from Cleveland Clinic’s Lerner Research Institute and Anesthesiology Institute found that the compound MDA7 induced beneficial immune responses that limited the development of Alzheimer’s disease.
Treatment with the compound restored cognition, memory and synaptic plasticity – a key neurological foundation of learning and memory – in an animal model.
“Cleveland Clinic dedicated two years of research into the examination of this compound and our findings show it could represent a novel therapeutic target in the treatment of Alzheimer’s disease,” Mohamed Naguib, lead researcher said in a statement.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Bearing in mind the note yesterday about the frequent hypes about wonder drugs to reverse Alzheimer’s disease, still we bring you today the news about a epilepsy drug that shows some promise in trails with animals. Lots of ifs and buts though as the Alzheimer is not the Human form but genetically modified and mice are not humans but still, we need some hope and continue to encourage research into novel ways to cure this terrible disease.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
With the disappointing news about the outcome of various clinical trails this month, the investors are looking how this shapes the trading environment in Alzheimer related companies for them. Follow the link to find a trading review that also, in reviewing the options for trading shows the current state of the trails and drug development for Alzheimer’s
Read all about it HERE
visit us at AlzheimerHeadlines.com